Skip to main content

Table 3 Measles and rubella immunity status among different groups vaccinated with various vaccination schedules and their response to revaccination, East of Mazandaran province, North of Iran

From: Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran

Groups (n) birth date GA: n = 98,1984–1998 GB: n = 295,1999–2003 GCa: n = 139,2004–2007 GD: n = 103,2008–2011 Total n = 635,1984–2011
vaccination status: A B C D different schedules
mMV: + +
MR: +
MMR: + one dose +  2 doses +  2 doses
Measles: 96 (98%) 250 (84.7%) 123 (88.5%) 88 (85.4%) 557 (87.7%)
Seroimmune n (%)
MCA ± SD
Response rate to revaccination respond/total(%)
25.15 ± 6.47 17.63 ± 7.21 19.34 ± 7.02 17.17 ± 7.42 19.19 ± 7.59
26/28(92.8%) 11/12(91.6%) 9/10(90%) 46/50(92%)
Rubella: 98(100%) 221(74.9%) 115(82.9%) 84(81.55%) 518(81.57%)
Seroimmune n (%)MCA ± SD 25.71 ± 2.29 23.07 ± 15.56 24.67 ± 12.51 20.09 ± 9.83 23.36 ± 13.14
Response rate to revaccination respond/ total(%) 34/36(94.4%) 15/16(93.7%) 7/7(100%) 56/59(94.3%)
  1. mMV Monovalent measles vaccine, MMR Measles-mumps-rubella vaccine, MR Measles rubella vaccine, yr Year, Mo Month, MCA Mean concentrations of antibody.
  2. a: these 2 groups (C&D) that were vaccinated with 2 doses of MMR vaccine after the age of 12 months: 16 + 15 = 31 (12.8%) and 24 + 19 = 43(17.7%) were susceptible to measles and rubella respectively.
\